Post-Operative Pain Management Market is expected to grow with High Probability Business Opportunity by 2030
Post-Operative Pain Management Market Overview
The pain arising post-surgery due to tissue injury and muscle spasm in a patient requires special attention because such kind of pain is a symptom that indicates a patient’s undiagnosed discomforts after surgery. This acute post-operative pain often tends to transform into chronic pain if not managed properly. Dovepress, a pain research journal, states that around 80% patients in the United States receive the desirable postoperative pain treatment. Enhanced post-operative pain management contributes to a patient’s quick rehabilitation and hence, sooner hospital discharge thereby, reducing medical expenses of the patient. This increases patient’s satisfaction which is expected to contribute largely to the global Post-Operative Pain Management Market expansion. Increasing prevalence of diseases that require surgical attention, like laparoscopic cholecystectomy and rise in the number of patients afflicted with diseases like cancer are other factors impelling the market growth. The rise in necessity of providing effective pain management with minimum side effect is creating immense opportunity for the market key players to invest in research and development activities which are anticipated to positively impact the postoperative pain management market expansion.
The post-operative pain management market is anticipated to reach USD 4,550 Million by 2030 at 6.80% CAGR during the forecast period 2022-2030, reveals the latest Market Research Future (MRFR) report. Post-operative pain is unpleasant and annoying, which, if not treated correctly and on time, can result in chronic pain, which may last for months. Post-operative pain is a common adverse outcome owing to physical distress, prolonged hospital stays, and the growing incidence of readmissions of patients after surgery. Post-operative pain management helps in minimizing patient discomfort, facilitating early mobilization, functional recovery along with preventing acute pain turning into chronic pain. Besides, it also helps to lessen the possibility of pulmonary, cardiac, and neuropathic pain complications, low cost of care, and cut down the risk of thrombosis.
Various
factors are propelling the post-operative pain management market growth. These
factors, as per the new Market Research Future (MRFR) report, include growing
incidence of diseases that need surgical treatments, development of novel drugs
for quick pain relief, increased R&D activities to develop high-quality
post-operative pain management solutions with minimum side effects, increasing
prevalence of various chronic diseases such as cardiovascular diseases, renal
diseases, cancer, and others, and increase in geriatric population. Additional
factors pushing market growth include the increasing number of cancer patients
and burgeoning demand for pain control devices and drugs.
Market Segmentation
The
MRFR report provides an all-inclusive segmental analysis of the post-operative
pain management market on the basis of target area, application, product, and
pain type.
Based
on pain type, the post-operative pain management market is segmented into
severe pain, moderate pain, and acute pain.
Based
on the product, the market is segmented into opioids, COX-2 inhibitors,
antiepileptic drugs, non-steroidal anti-inflammatory drugs, and other
analgesics.
Based
on the application, the market is segmented into migraine, musculoskeletal
pain, neuropathic pain, arthritic pain, cancer pain, and others. Of these, the
cancer pain segment will have the largest share in the market over the forecast
period.
Based
on target area, the market is segmented into arms, hand, legs, back, and
others.
Regional Analysis
By
region, the post-operative pain management market report covers the latest
trends and growth opportunities across the Asia Pacific (APAC), the Americas,
Europe, and the Middle East and Africa. Of these, the Americas will dominate
the market over the forecast period. This is chiefly on account of the presence
of well-developed healthcare infrastructure in the region and the huge patient
pool undergoing surgical procedures.
The
market in Europe is predicted to have the second-largest share in the market
over the forecast period. This is chiefly on account of the increasing R&D
activities for the launch of new drugs with minimal side-effects.
The
market in the APAC region is predicted to grow at the fastest pace over the
forecast period. This is chiefly on account of the growing incidence of chronic
diseases that needs surgical treatment coupled with an increase in the
geriatric population.
The
market in the MEA is predicted to have steady growth over the forecast period.
This is chiefly on account of poor primary health care services, especially in
the region’s underdeveloped areas and lack of awareness.
Key players
Teva Pharmaceutical
Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson
(U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc.
(US), and Valeant Pharmaceuticals International Inc. (Canada) are the post-operative pain
management market Players.
Industry Update
April 2019: American
Society of Regional Anesthesia and Pain Medicine (ASRA) reported that regional anaesthesia with lidocaine infusion reduces
postoperative pain for patients undergoing primary hip arthroplasty, according to research from Stanford University in Stanford,
CA.
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com

Comments
Post a Comment